New Immuno-Oncology Startup out of Baltimore Launches at JPM Healthcare Conference with Veteran Board, Advisors and Officers

Published on :

New Immuno-Oncology Startup out of Baltimore Launches at JPM Healthcare Conference with Veteran Board, Advisors and Officers VerImmune’s Novel technology platform enables redirection of pre-existing natural immunity towards fighting cancer BALTIMORE (Originally Published via PRWEB) JANUARY 13, 2020 VerImmune Announces New Board, Advisors and Officers VerImmune, a privately-owned immuno-oncology biotechnology company developing a first-in-class broad spectrum [….]